In today's episode of India Ascends, US President Donald Trump on Thursday announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical drugs, starting October 1, 2025. Yet India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America, will only face a limited impact by the move. NDTV's Gaurie Dwivedi decodes.